Viewing Study NCT06530550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:51 PM
Ignite Modification Date: 2026-05-11 @ 12:51 PM
Study NCT ID: NCT06530550
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2024-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, T-Cell View
None NK-LGL Leukemia View
None T-LGL Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Indolent T/NK-cell lymphomas View
None PI3K inhibitor View